Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 23.18B | 6.79B | 6.25B | 19.14B | 16.39B | 13.90B |
Gross Profit | 29.87B | 6.79B | 6.25B | 6.56B | 6.89B | 5.18B |
EBITDA | -178.00M | 20.52B | 18.58B | 14.76B | 8.58B | 6.49B |
Net Income | 3.47B | 3.71B | 3.52B | 5.18B | 4.71B | 3.02B |
Balance Sheet | ||||||
Total Assets | 403.40B | 445.22B | 403.40B | 389.41B | 399.18B | 245.65B |
Cash, Cash Equivalents and Short-Term Investments | 83.90B | 88.04B | 83.90B | 87.79B | 103.57B | 40.17B |
Total Debt | 269.21B | 330.19B | 269.21B | 141.79B | 140.47B | 85.47B |
Total Liabilities | 369.41B | 409.43B | 369.41B | 355.31B | 370.37B | 223.30B |
Stockholders Equity | 33.48B | 35.36B | 33.48B | 33.16B | 28.56B | 22.05B |
Cash Flow | ||||||
Free Cash Flow | -18.09B | 5.27B | -6.05B | -12.20B | 9.57B | -2.40B |
Operating Cash Flow | -16.13B | 6.33B | -4.09B | -11.38B | 10.55B | -1.64B |
Investing Cash Flow | -11.99B | -2.34B | -3.88B | -1.23B | -31.13B | -11.13B |
Financing Cash Flow | 17.16B | -1.94B | -2.99B | 450.00M | 72.19B | 20.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $28.20B | 33.17 | 19.15% | 0.78% | 12.25% | 20.76% | |
78 Outperform | $33.66B | 15.78 | 18.22% | 1.17% | 9.01% | 14.86% | |
77 Outperform | $227.72B | 16.11 | 14.13% | 2.60% | 6.31% | 45.50% | |
74 Outperform | $172.88B | 25.62 | 15.59% | 1.08% | 4.64% | 54.26% | |
71 Outperform | $51.48B | 23.24 | 10.63% | 0.02% | 6.28% | 5.37% | |
71 Outperform | $220.16B | 15.81 | 12.78% | 1.67% | -0.34% | 45.85% | |
68 Neutral | $17.10B | 11.44 | 9.70% | 3.58% | 11.11% | -4.78% |